MRPS23 is a novel prognostic biomarker and promotes glioma progression.

Authors:
Wang Q; Chen G; Liu L; Peng X; Yang X and 2 more

Journal:
Aging (Albany NY)

Publication Year: 2024

DOI:
10.18632/aging.205493

PMCID:
PMC10911364

PMID:
38301044

View on PubMed View on PMC View Publisher
Journal Information

Full Title: Aging (Albany NY)

Abbreviation: Aging (Albany NY)

Country: Unknown

Publisher: Unknown

Language: N/A

Publication Details

Subject Category: Geriatrics

Available in Europe PMC: Yes

Available in PMC: Yes

PDF Available: No

Related Papers from Same Journal
5-methylcytosine RNA modification regulators-based patterns and features of immune microenvironment…
Ding Y; Bajpai AK; Wu F and 7 more (2024) - Transparency Score: 5/6
Aberrant RBMX expression is relevant for cancer prognosis and immunotherapy response.
Sheng Y; Lei K; Sun C and 4 more (2024) - Transparency Score: 3/6
A circRNA ceRNA network involved in cognitive dysfunction after chronic cerebral hypoperfusion.
Jiang WR; Zhou YM; Wu W and 4 more (2024) - Transparency Score: 3/6
Activation of Notch-1 signaling pathway in macrophages to secrete PD-L1 and regulate cytotoxicity o…
Li W; Wu L; Huang C and 4 more (2024) - Transparency Score: 3/6
Anoikis-related gene signature is associated with immune infiltration and predicts the prognosis of…
Wu Y; Zhou Z; Qi Q and 3 more (2024) - Transparency Score: 3/6
View All Papers from This Journal
Transparency Score
3/6
50.0% Transparent
Transparency Indicators
Click on green indicators to view evidence text
Core Indicators
Data Sharing
Code Sharing
Evidence found in paper:

"CONFLICTS OF INTEREST: The authors declare that they have no conflicts of interest."

Evidence found in paper:

"FUNDING: This study was supported by grants from Sichuan Medical Research Project Plan (No. S22045)."

Protocol Registration
Open Access
Paper is freely available to read
Additional Indicators
Replication
Novelty Statement
Assessment Info

Tool: rtransparent

OST Version: N/A

Last Updated: Aug 05, 2025